JANE STREET GROUP, LLC - CATABASIS PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of CATABASIS PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2021$58,000
-55.7%
27,498
-54.9%
0.00%
Q4 2020$131,000
+48.9%
61,004
+346.5%
0.00%
Q2 2020$88,000
+1.1%
13,663
-7.3%
0.00%
Q4 2019$87,00014,7360.00%
Other shareholders
CATABASIS PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Eversept Partners, LP 522,042$1,117,1700.13%
XTX MARKETS LLC 26,041$56,0000.12%
Samsara BioCapital, LLC 300,000$642,0000.06%
Ikarian Capital, LLC 650,000$1,392,0000.06%
Opaleye Management Inc. 187,750$402,0000.05%
SABBY MANAGEMENT, LLC 108,026$231,0000.04%
Anson Funds Management LP 97,601$209,0000.04%
Virtu Financial LLC 83,221$178,0000.02%
GSA CAPITAL PARTNERS LLP 47,084$101,0000.02%
WEXFORD CAPITAL LP 19,512$42,0000.01%
View complete list of CATABASIS PHARMACEUTICALS IN shareholders